Skip to main content

JANE STREET GROUP, LLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1595888 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$1,898,424 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Derivatives in RIGL

reported options exposure · as of Jun 30, 2026
CallValue
$285,576
CallShares
7,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $285,576 7,300
2026-03-31 $1,898,424 70,208
2026-03-31 $419,120 15,500
2025-12-31 $11,816,067 275,883
2025-12-31 $1,332,013 31,100
2025-12-31 $252,697 5,900
2025-09-30 $430,616 15,200
2025-09-30 $9,119,256 321,894
2025-06-30 $324,647 17,333
2024-12-31 $1,051,720 62,528
2024-09-30 $414,028 25,589
2024-06-30 $870,167 105,860
2024-03-31 $68,455 46,254
2023-12-31 $73,620 50,773
2023-09-30 $25,989 24,064
2023-06-30 $85,923 66,608
2023-03-31 $170,283 129,003
2022-12-31 $158,200 105,467
2022-09-30 $286,201 242,544
2022-06-30 $81,193 71,853
2022-03-31 $173,467 58,016
2021-12-31 $220,611 83,250
2021-12-31 $34,715 13,100
2021-12-31 $64,925 24,500
2021-09-30 $484,242 133,400
2021-09-30 $326,442 89,929
2021-09-30 $381,513 105,100
2021-06-30 $121,954 28,100
2021-06-30 $274,288 63,200
2021-06-30 $493,171 113,634
2021-03-31 $49,689 14,529
2020-12-31 $179,081 51,166
2020-09-30 $74,287 30,953
2020-06-30 $175,661 95,990